We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Singular Genomics Systems In
4 own
5 watching
Current Price
$15.38
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
23.95M
52-Week High
19.80000
52-Week Low
5.34000
Average Volume
0.03M
Dividend Yield
--
P/E Ratio
--
Market Capitalization23.95M52-Week High19.8000052-Week Low5.34000Average Volume0.03MDividend Yield--P/E Ratio--What does the Singular Genomics Systems In do?
Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The Company is also engaged in developing PX, which is a development-stage multiomics platform.
Read More
How much money does Singular Genomics Systems In make?
News & Events about Singular Genomics Systems In.
Globe Newswire
1 year ago
The datasets are the latest to validate the performance and plug-and-play capability of the G4 across multiple applicationsSAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics ...
Globe Newswire
1 year ago
- New next-generation sequencing kit maximizes throughput and decreases the cost for single cell experiments - - Company announces increased quality and throughput specifications of the G4 Sequencing Platform - SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: ...
Globe Newswire
2years ago
SAN DIEGO, June 03, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 43rd Annual Global ...
Ticker Report
2years ago
Singular Genomics Systems, Inc. (NASDAQ:OMIC Get Rating) shares dropped 10.3% on Friday . The company traded as low as $7.05 and last traded at $7.06. Approximately 19,760 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 432,202 shares. The stock...
Frequently Asked Questions
Frequently Asked Questions
What is Singular Genomics Systems In share price today?
Can Indians buy Singular Genomics Systems In shares?
How can I buy Singular Genomics Systems In shares from India?
Can Fractional shares of Singular Genomics Systems In be purchased?
What are the documents required to start investing in Singular Genomics Systems In stocks?
What is today’s traded volume of Singular Genomics Systems In?
What is today’s market capitalisation of Singular Genomics Systems In?
What is the 52-Week High and Low Range of Singular Genomics Systems In?
What percentage is Singular Genomics Systems In down from its 52-Week High?
What percentage is Singular Genomics Systems In up from its 52-Week Low?
Current Price
$15.38
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.